Mycobacterium genavense Infection Presenting as an Endobronchial Polyp and Upper Lobe Atelectasis

Am J Respir Crit Care Med. 2020 Dec 1;202(11):e144-e145. doi: 10.1164/rccm.202005-1652IM.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Antitubercular Agents / therapeutic use
  • Bronchoalveolar Lavage Fluid
  • Bronchoscopy
  • Clarithromycin / therapeutic use
  • Ethambutol / therapeutic use
  • Glucocorticoids / adverse effects
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Methotrexate / adverse effects
  • Mycobacterium Infections, Nontuberculous / complications
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / immunology
  • Mycobacterium*
  • Nucleic Acid Amplification Techniques
  • Polymyalgia Rheumatica / drug therapy*
  • Polyps / diagnostic imaging*
  • Polyps / etiology
  • Prednisolone / adverse effects
  • Pulmonary Atelectasis / diagnostic imaging*
  • Pulmonary Atelectasis / etiology
  • Rifampin / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tuberculosis, Pulmonary / complications
  • Tuberculosis, Pulmonary / diagnosis*
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / immunology

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Glucocorticoids
  • Immunosuppressive Agents
  • Ethambutol
  • Prednisolone
  • Clarithromycin
  • Rifampin
  • Methotrexate

Supplementary concepts

  • Mycobacterium genavense